Octreotide in the treatment of neuroendocrine carcinomas: Is the success achieved?
Diagnosis and treatment of functioning and non-functioning neuroendocrine tumors is a challenging task. Surgeru remains the only radical method of treatment of these tumors, but tumors often are diagnosed at the stage of metastasis, when only palliative treatment is possible. Octreotide in patients...
Saved in:
| Main Author: | L. Yu. Morgunov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
QUASAR, LLC
2015-06-01
|
| Series: | Исследования и практика в медицине |
| Subjects: | |
| Online Access: | https://www.rpmj.ru/rpmj/article/view/64 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Multidisciplinary Approach to Managing Carcinoid Syndrome in Pregnant Women: Ensuring Maternal and Fetal Safety Trough Interdisciplinary Collaboration
by: Andreea Elena CONSTANTIN, et al.
Published: (2025-06-01) -
Development of a method for preparing octreotide derivative for diagnosis of neuroendocrine tumors
by: M. S. Larkina, et al.
Published: (2019-10-01) -
Diagnostic accuracy of technetium-99m-octreotide in imaging neuroendocrine tumors, Oman hospital experience with literature review
by: Naima Al Bulushi, et al.
Published: (2019-04-01) -
Pharmacoeconomic analysis of lanreotide and prolonged-release octreotide in first- and second-line therapy of acromegaly
by: I. S. Krysanov, et al.
Published: (2025-05-01) -
Comparative analysis of adverse event profiles of lanreotide and octreotide in somatostatin-responsive endocrine and neoplastic diseases
by: Le Wang, et al.
Published: (2025-05-01)